WHO ICTRP trial

Analgesic Effect of Adding Midazolam and Fentanyl to Intrathecal Bupivacaine…

IRCT2014061810340N9 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting

Key facts

Trial ID IRCT2014061810340N9
Public title Analgesic Effect of Adding Midazolam and Fentanyl to Intrathecal Bupivacaine 0.05%
Scientific title Analgesic Effect of Adding Midazolam and Fentanyl to Intrathecal Bupivacaine 0.05% in Patients with Orthopedic Surgery of Lower Limbs
Primary sponsor Golestan University of Medical Science
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Not Recruiting
Study type interventional
Countries Iran (Islamic Republic of)
Conditions Pain. Pain in limb;Pain in limb
Interventions Intervention 1: 15 mg of bupivacaine 0.5% (3 cc) with 0.5 mg of midazolam. Intervention 2: 15 mg of bupivacaine 0.5% (3 cc) with fentanyl 25 microgram (µg). Intervention 3: 15 milligram (mg) of bupivacaine 0.5% (equivalent to 3 cc) with 0.5…
Registration date Sep 25, 2016
Target size 75
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations